JPS55127321A - Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell - Google Patents

Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell

Info

Publication number
JPS55127321A
JPS55127321A JP3420580A JP3420580A JPS55127321A JP S55127321 A JPS55127321 A JP S55127321A JP 3420580 A JP3420580 A JP 3420580A JP 3420580 A JP3420580 A JP 3420580A JP S55127321 A JPS55127321 A JP S55127321A
Authority
JP
Japan
Prior art keywords
cell
antibody
crosssfertilization
against human
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3420580A
Other languages
English (en)
Other versions
JPS6362518B2 (ja
Inventor
Chiyunnshiu Kun Patoritsuku
Goorudosutain Gideon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21807977&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS55127321(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS55127321A publication Critical patent/JPS55127321A/ja
Publication of JPS6362518B2 publication Critical patent/JPS6362518B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fuel Cell (AREA)
JP3420580A 1979-03-20 1980-03-19 Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell Granted JPS55127321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/022,132 US4363799A (en) 1979-03-20 1979-03-20 Monoclonal antibody to human T cells, and methods for preparing same

Publications (2)

Publication Number Publication Date
JPS55127321A true JPS55127321A (en) 1980-10-02
JPS6362518B2 JPS6362518B2 (ja) 1988-12-02

Family

ID=21807977

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3420580A Granted JPS55127321A (en) 1979-03-20 1980-03-19 Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell
JP63101496A Granted JPS63294779A (ja) 1979-03-20 1988-04-26 ハイブリドマ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP63101496A Granted JPS63294779A (ja) 1979-03-20 1988-04-26 ハイブリドマ

Country Status (22)

Country Link
US (1) US4363799A (ja)
EP (1) EP0017381B1 (ja)
JP (2) JPS55127321A (ja)
AT (1) ATE14233T1 (ja)
AU (1) AU544771B2 (ja)
CA (1) CA1149281A (ja)
DE (2) DE3070848D1 (ja)
DK (1) DK154086C (ja)
ES (1) ES489757A0 (ja)
FI (1) FI75362C (ja)
GR (1) GR68040B (ja)
HK (1) HK23686A (ja)
IE (1) IE50420B1 (ja)
IL (1) IL59622A (ja)
MY (1) MY8600535A (ja)
NO (1) NO159882C (ja)
NZ (1) NZ193173A (ja)
PH (1) PH17056A (ja)
PT (1) PT70978B (ja)
SG (1) SG6486G (ja)
YU (1) YU43913B (ja)
ZA (1) ZA801604B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5859994A (ja) * 1981-07-01 1983-04-09 ザ　ボード　オブ　リージェンツ，ザ　ユニバーシティ　オブ　テキサス　システム 組換えモノクローナル抗体
JPS59196822A (ja) * 1983-02-16 1984-11-08 ディナーファーバー・キャンサー・インスティテュート・インコーポレイテッド モノクロ−ナル抗体
WO1985002188A1 (en) * 1983-11-09 1985-05-23 Toshitada Takahashi Novel monoclonal antibody

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510244A (en) * 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
US4582797A (en) * 1980-09-25 1986-04-15 The Salk Institute For Biological Studies Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
DE3105150A1 (de) * 1981-02-12 1982-08-19 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Herstellung von anti-t-lymphozyten-globulin.
US4659655A (en) * 1981-11-25 1987-04-21 Bio-Response, Inc. Method for isolating product-producing cells
US4657852A (en) * 1982-04-02 1987-04-14 The Board Of Trustees Of The Leland Stanford Junior University Method for B cell typing of total human lymphocyte sample
US4471056A (en) * 1982-04-02 1984-09-11 The Board Of Trustees Of The Leland Stanford Junior University Method for HLA-DR typing of total human lymphocyte sample
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4500637A (en) * 1982-07-19 1985-02-19 The United States Of America As Represented By The Department Of Health And Human Services Prevention of graft versus host disease following bone marrow transplantation
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US4882424A (en) * 1987-05-11 1989-11-21 Dana-Farber Cancer Institute, Inc. Activation antigen
US5298419A (en) * 1988-03-31 1994-03-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US4892933A (en) * 1988-04-20 1990-01-09 New England Deaconess Hospital Corporation Monoclonal antibody for colorectal carcinoma
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
IT1249051B (it) * 1991-02-26 1995-02-11 Italfarmaco Spa Immunotossina da anticorpi monoclonali anti-cd5
CA2310805A1 (en) 1997-11-24 1999-06-03 Johnson T. Wong Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US20060154903A1 (en) * 2004-09-10 2006-07-13 Cornell Research Foundation, Inc. Betulinol derivatives as anti-cancer agents
BR112013006146B8 (pt) * 2010-09-15 2022-10-11 Dow Agrosciences Llc Anticorpos monoclonais, linhagens de célula de hibridoma e métodos para identificar a presença e para a determinação quantitativa de uma enzima aad-1 que confere resistência ao ácido 2,4-diclorofenoxiacético
JP2022530026A (ja) 2019-04-24 2022-06-27 ハイデルベルク ファルマ リサーチ ゲゼルシャフト ミット ベシュレンクテル ハフツング アマトキシン抗体薬物複合体及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5859994A (ja) * 1981-07-01 1983-04-09 ザ　ボード　オブ　リージェンツ，ザ　ユニバーシティ　オブ　テキサス　システム 組換えモノクローナル抗体
JPH0367678B2 (ja) * 1981-07-01 1991-10-23 Yunibaashitei Obu Tekisasu Shisutemu Za
JPS59196822A (ja) * 1983-02-16 1984-11-08 ディナーファーバー・キャンサー・インスティテュート・インコーポレイテッド モノクロ−ナル抗体
JPH0440999B2 (ja) * 1983-02-16 1992-07-06 Danaafuaabaa Kyansaa Inst Inc
WO1985002188A1 (en) * 1983-11-09 1985-05-23 Toshitada Takahashi Novel monoclonal antibody
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
JPH0340B2 (ja) * 1983-11-09 1991-01-07 Aichi Prefecture

Also Published As

Publication number Publication date
FI75362B (fi) 1988-02-29
JPS6362518B2 (ja) 1988-12-02
NO800793L (no) 1980-09-22
ZA801604B (en) 1981-10-28
NO159882C (no) 1989-02-15
ATE14233T1 (de) 1985-07-15
DE17381T1 (de) 1984-10-11
ES8103975A1 (es) 1981-04-16
CA1149281A (en) 1983-07-05
EP0017381A2 (en) 1980-10-15
NO159882B (no) 1988-11-07
DK154086B (da) 1988-10-10
AU544771B2 (en) 1985-06-13
DK154086C (da) 1989-02-27
DK117280A (da) 1980-09-21
PT70978B (en) 1981-06-25
JPH0223156B2 (ja) 1990-05-23
DE3070848D1 (en) 1985-08-14
SG6486G (en) 1986-08-01
IL59622A (en) 1983-12-30
EP0017381A3 (en) 1981-01-07
JPS63294779A (ja) 1988-12-01
IE50420B1 (en) 1986-04-16
FI75362C (fi) 1988-06-09
IL59622A0 (en) 1980-06-30
EP0017381B1 (en) 1985-07-10
NZ193173A (en) 1984-07-06
GR68040B (ja) 1981-10-27
FI800846A (fi) 1980-09-21
AU5659880A (en) 1980-09-25
MY8600535A (en) 1986-12-31
ES489757A0 (es) 1981-04-16
PH17056A (en) 1984-05-17
PT70978A (en) 1980-04-01
HK23686A (en) 1986-04-11
YU74280A (en) 1984-08-31
US4363799A (en) 1982-12-14
IE800565L (en) 1980-09-20
YU43913B (en) 1989-12-31

Similar Documents

Publication Publication Date Title
JPS55127321A (en) Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell
JPS5695123A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell
JPS55145616A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody against human helper t cell
JPS5695121A (en) Hybrid cell line* antibody and method of manufacturing complementtfixing monoclonal antibody to human suppressor t cell
YU44321B (en) Process for obtaining a monoclonal antibody
ES8200559A1 (es) Un anticuerpo monoclonal
AU545181B2 (en) Hybridoma for producing monoclonal antibodies
YU43224B (en) Method of obtaining monoclonal antibodies